Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,710 total articles

Diodes SVP Emily Yang Divests $202K in Shares Amid Market Shifts

Diodes SVP Emily Yang Divests $202K in Shares Amid Market Shifts

Emily Yang, Senior Vice President of Worldwide Sales and Marketing at Diodes Inc. (NASDAQ:DIOD), executed a sale of company stock worth $202,930 on May 15, 2026. This transaction occurs against a backdrop of recent market volatility for the stock, although the company recently reported robust financial results and announced key leadership changes.

Insider Activity at Nexstar Media Highlights Executive Transactions Amid Strong Quarterly Performance

Insider Activity at Nexstar Media Highlights Executive Transactions Amid Strong Quarterly Performance

The recent sale of common stock by Dan Lanzano, President, National Advertising Sales at Nexstar Media Group Inc., was disclosed via an SEC Form 4 filing. This transaction occurs against a backdrop of positive corporate developments for Nexstar, including robust first-quarter financial reporting that exceeded market expectations and several key exe…

Donegal Mutual Insurance Increases Stake in Donegal Group Stock

Donegal Mutual Insurance Increases Stake in Donegal Group Stock

Donegal Mutual Insurance Co., a significant owner of Donegal Group Inc., recently increased its investment by acquiring 17,000 shares of Class A Common Stock. This transaction, which totaled approximately $293,182, occurred amidst market trading that has seen the stock decline over the last year. Separately, the company's annual shareholder meeting…

Director Bienaime's Stock Purchase at Immunome Signals Internal Confidence Amid Drug Development Milestones

Director Bienaime's Stock Purchase at Immunome Signals Internal Confidence Amid Drug Development Milestones

Immunome director Jean Jacques Bienaime recently acquired a substantial block of the company's common stock, signaling internal confidence. This activity is coupled with positive developments regarding Immunome's drug candidate, varegacestat. The company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for treatin…

Director's Buy Signal for Harrow Shares Amid Mixed Financial Reports

Director's Buy Signal for Harrow Shares Amid Mixed Financial Reports

A director at Harrow, Inc. recently increased her personal stake in the company by purchasing 1,000 shares. This insider activity occurs against a backdrop of mixed financial news for the firm, which reported first-quarter results that missed analyst expectations. The transaction takes place while the stock is trading near the purchase price but re…